Kechen Ban
Impact in
-
- Trauma, Hemostasis, Coagulopathy, Resuscitation
-
- FOXO transcription factor regulation
- Ubiquitin and proteasome pathways
- Histone Deacetylase Inhibitors Research
- Protein Degradation and Inhibitors
Papers in
-
- Ubiquitin and proteasome pathways 2
-
- Clinical Nutrition and Gastroenterology 5
- Co-authors
- Rosemary A. Kozar (11 shared papers)Joya Chandra (7 shared papers)Claudia P. Miller (5 shared papers)Zhanglong Peng (6 shared papers)Mark Munsell (2 shared papers)Melanie Dujka (1 shared paper)Michael A. Palladino (2 shared papers)David J. McConkey (2 shared papers)
- Journals
- Blood (4 papers)Shock (3 papers)PLoS ONE (3 papers)Neuro-Oncology (2 papers)Molecular and Cellular Biochemistry (2 papers)
- Partner nations
- United StatesChinaMalaysia
In The Last Decade
Kechen Ban
30 papers receiving 949 citations
Peers
Comparison fields: 5 of 88
- Critical Care and Intensive Care Medicine 47
- Molecular Biology 584
- Hematology 80
- Cancer Research 104
- Oncology 131
Countries citing papers authored by Kechen Ban
This map shows the geographic impact of Kechen Ban's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kechen Ban with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kechen Ban more than expected).
Fields of papers citing papers by Kechen Ban
This network shows the impact of papers produced by Kechen Ban. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kechen Ban. The network helps show where Kechen Ban may publish in the future.
Co-authors
The 25 scholars most cited alongside Kechen Ban, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 271 | |
| 2 | 2007 | 167 | |
| 3 | 2016 | 43 | |
| 4 | 2008 | 42 | |
| 5 | 2017 | 39 | |
| 6 | 2009 | 35 | |
| 7 | 2002 | 33 | |
| 8 | 2015 | 27 | |
| 9 | 2010 | 26 | |
| 10 | 2012 | 26 | |
| 11 | 2006 | 26 | |
| 12 | 2013 | 26 | |
| 13 | 2009 | 25 | |
| 14 | 2011 | 22 | |
| 15 | 2014 | 21 | |
| 16 | 2018 | 20 | |
| 17 | 2011 | 18 | |
| 18 | 2012 | 17 | |
| 19 | 2008 | 16 | |
| 20 | 2020 | 15 |
About Kechen Ban
Kechen Ban is a scholar working on Molecular Biology, Nutrition and Dietetics, Hematology, Physiology and Endocrinology, Diabetes and Metabolism, having authored 31 papers that have together received 967 indexed citations. Recurring topics across this work include Clinical Nutrition and Gastroenterology (5 papers), Diet and metabolism studies (4 papers), Chronic Myeloid Leukemia Treatments (3 papers), Organ Transplantation Techniques and Outcomes (2 papers), Ubiquitin and proteasome pathways (2 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (2 papers), Renal Transplantation Outcomes and Treatments (2 papers) and Optical Coherence Tomography Applications (2 papers). The work is most often cited by research in Critical Care and Intensive Care Medicine (47 citations), Molecular Biology (584 citations), Hematology (80 citations), Cancer Research (104 citations) and Oncology (131 citations). Kechen Ban has collaborated with scholars based in United States, China and Malaysia. Frequent co-authors include Rosemary A. Kozar, Joya Chandra, Claudia P. Miller, Zhanglong Peng, Mark Munsell, Melanie Dujka, Michael A. Palladino, David J. McConkey, Mingguang Liu and Bingbing Dai. Their work appears in journals such as Blood, Shock, PLoS ONE, Neuro-Oncology and Molecular and Cellular Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.